5.2999
Teladoc Health Inc stock is traded at $5.2999, with a volume of 1.48M.
It is up +1.62% in the last 24 hours and down -1.21% over the past month.
Teladoc Health Inc is engaged in the provision of virtual healthcare services, connecting patients, providers, and healthcare systems through technology-enabled platforms. The company has two reportable segments: Integrated Care and BetterHelp. The Integrated Care segment provides virtual healthcare solutions, including primary care, mental health, chronic care management, and telehealth enablement services for employers, insurers, and healthcare systems, mainly on a business-to-business basis, while the BetterHelp segment offers direct-to-consumer online mental health services, including counseling and therapy delivered through digital platforms. It generates the majority of its revenue from the Integrated Care segment.
See More
Previous Close:
$5.22
Open:
$5.3
24h Volume:
1.48M
Relative Volume:
0.24
Market Cap:
$954.48M
Revenue:
$2.53B
Net Income/Loss:
$-200.32M
P/E Ratio:
-4.645
EPS:
-1.141
Net Cash Flow:
$133.23M
1W Performance:
-0.29%
1M Performance:
-1.21%
6M Performance:
-40.60%
1Y Performance:
-26.73%
Teladoc Health Inc Stock (TDOC) Company Profile
Name
Teladoc Health Inc
Sector
Industry
Phone
(203) 635-2002
Address
155 E 44TH STREET, NEW YORK, NY
Compare TDOC vs VEEV, BTSG, TEM, HQY, WAY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
TDOC
Teladoc Health Inc
|
5.29 | 920.20M | 2.53B | -200.32M | 133.23M | -1.141 |
|
VEEV
Veeva Systems Inc
|
158.77 | 24.73B | 3.20B | 908.91M | 1.39B | 5.4168 |
|
BTSG
Brightspring Health Services Inc
|
46.06 | 8.71B | 12.91B | 104.80M | 394.69M | 0.8769 |
|
TEM
Tempus Ai Inc
|
49.00 | 7.70B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
HQY
Healthequity Inc
|
80.46 | 6.59B | 1.31B | 215.20M | 408.32M | 2.4627 |
|
WAY
Waystar Holding Corp
|
22.50 | 4.12B | 1.10B | 112.09M | 283.19M | 0.6096 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-10-26 | Upgrade | Deutsche Bank | Hold → Buy |
| Feb-26-26 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-09-25 | Initiated | Barclays | Equal Weight |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| Jul-25-25 | Initiated | Mizuho | Neutral |
| Nov-15-24 | Initiated | Goldman | Buy |
| Sep-17-24 | Reiterated | Jefferies | Hold |
| Feb-29-24 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Jan-17-24 | Downgrade | DA Davidson | Buy → Neutral |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Apr-12-23 | Initiated | Stephens | Equal-Weight |
| Feb-23-23 | Upgrade | SVB Securities | Market Perform → Outperform |
| Oct-24-22 | Upgrade | Guggenheim | Sell → Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-17-22 | Downgrade | Guggenheim | Neutral → Sell |
| Aug-12-22 | Initiated | DA Davidson | Buy |
| Aug-02-22 | Downgrade | Berenberg | Buy → Hold |
| Aug-02-22 | Downgrade | Cowen | Outperform → Market Perform |
| Jul-28-22 | Downgrade | Goldman | Buy → Neutral |
| Jul-28-22 | Downgrade | Needham | Buy → Hold |
| Jul-06-22 | Reiterated | BofA Securities | Neutral |
| May-05-22 | Downgrade | Argus | Buy → Hold |
| Apr-28-22 | Downgrade | Citigroup | Buy → Neutral |
| Apr-28-22 | Downgrade | Credit Suisse | Outperform → Neutral |
| Apr-28-22 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-28-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-28-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-28-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-28-22 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Mar-03-22 | Upgrade | Argus | Hold → Buy |
| Feb-23-22 | Reiterated | BofA Securities | Neutral |
| Feb-23-22 | Reiterated | Craig Hallum | Hold |
| Feb-23-22 | Reiterated | Evercore ISI | In-line |
| Feb-23-22 | Reiterated | Goldman | Buy |
| Feb-23-22 | Reiterated | JP Morgan | Overweight |
| Feb-23-22 | Reiterated | KeyBanc Capital Markets | Overweight |
| Feb-23-22 | Reiterated | Needham | Buy |
| Feb-23-22 | Reiterated | Oppenheimer | Outperform |
| Feb-23-22 | Reiterated | Stifel | Hold |
| Feb-11-22 | Initiated | Goldman | Buy |
| Feb-08-22 | Reiterated | Piper Sandler | Overweight |
| Dec-02-21 | Resumed | Jefferies | Hold |
| Nov-22-21 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-28-21 | Reiterated | Barclays | Equal Weight |
| Oct-28-21 | Reiterated | BofA Securities | Neutral |
| Oct-28-21 | Reiterated | Canaccord Genuity | Buy |
| Oct-28-21 | Reiterated | Citigroup | Buy |
| Oct-28-21 | Reiterated | Craig Hallum | Hold |
| Oct-28-21 | Reiterated | Needham | Buy |
| Oct-28-21 | Reiterated | Oppenheimer | Outperform |
| Oct-28-21 | Reiterated | Piper Sandler | Overweight |
| Oct-28-21 | Reiterated | UBS | Neutral |
| Oct-19-21 | Initiated | Wells Fargo | Overweight |
| Aug-02-21 | Downgrade | Argus | Buy → Hold |
| Jul-28-21 | Downgrade | Deutsche Bank | Buy → Hold |
| May-28-21 | Initiated | Robert W. Baird | Neutral |
| Apr-15-21 | Initiated | Needham | Buy |
| Jan-07-21 | Initiated | BTIG Research | Buy |
| Dec-22-20 | Initiated | Evercore ISI | In-line |
| Dec-07-20 | Downgrade | Stephens | Overweight → Equal-Weight |
| Dec-04-20 | Initiated | Goldman | Neutral |
| Nov-13-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-22-20 | Initiated | DA Davidson | Buy |
| Sep-02-20 | Upgrade | Berenberg | Hold → Buy |
| Aug-17-20 | Upgrade | Credit Suisse | Neutral → Outperform |
| Jul-14-20 | Initiated | Citigroup | Buy |
| Jul-13-20 | Initiated | Argus | Buy |
| Jul-07-20 | Initiated | Stephens | Overweight |
| Apr-30-20 | Reiterated | KeyBanc Capital Markets | Overweight |
| Apr-13-20 | Initiated | SVB Leerink | Outperform |
| Mar-31-20 | Downgrade | Berenberg | Buy → Hold |
| Mar-25-20 | Downgrade | Craig Hallum | Buy → Hold |
| Mar-16-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-12-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-28-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-12-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-10-20 | Initiated | UBS | Neutral |
| Jan-09-20 | Downgrade | BofA/Merrill | Buy → Neutral |
View All
Teladoc Health Inc Stock (TDOC) Latest News
Teladoc Health pushes for new solutions to address gaps in rural healthcare access - Traders Union
Did Teladoc Health, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - GuruFocus
Glen Tullman | Notable Leaders in Health Care 2026 - Crain's Chicago Business
Teladoc Health Q4 preview: Here's what to expect - MSN
Teladoc rises following appointment of new board member, investor letter - MSN
Teladoc Health: Improving Fundamentals Support A Turnaround Story (NYSE:TDOC) - Seeking Alpha
Teladoc Health (LTS:0LDR) Total Membership (K) - GuruFocus
Teladoc (TDOC) Dips More Than Broader Market: What You Should Know - Yahoo Finance
Teladoc Health, Inc. virtual diabetes prevention boosts engagement among Medicare beneficiaries - Traders Union
Mental Health Screening Market to Reach USD 2.78 Billion by 2033 - openPR.com
Future Prospects: Key Trends Shaping the Chatbots for Mental Health and Therapy Market Until 2030 - openPR.com
TDOC News | TELADOC HEALTH INC (NYSE:TDOC) - ChartMill
Smart Clinic Market 2026- 2033 Overview: Share, Size, Value, - openPR.com
1 In 3 Americans Use AI For Mental Health Advice. These Online Therapy Services Are A Better Option - Forbes
Teladoc (TDOC) up 3.2% since last earnings report: Can it continue? - MSN
Teladoc Health (TDOC): Analyst Raises Price Target to $6.00 | TD - GuruFocus
Evercore Maintains Teladoc Health(TDOC.US) With Hold Rating, Raises Target Price to $6 - Moomoo
Teladoc Health, Inc. (TDOC) latest stock news and headlines - Yahoo Finance UK
The Technical Signals Behind (TDOC) That Institutions Follow - Stock Traders Daily
Teladoc Health, Inc. launches new push for integrated virtual healthcare services - Traders Union
Teladoc Health (NYSE: TDOC) details 2026 proxy, 2025 results and CEO pay mix - Stock Titan
Global Telehealth Market Expected to Surpass USD 2 Trillion by 2034, Fueled by Rapid Digital Healthcare Advancements | DelveInsight - Barchart.com
Teladoc Health, Inc. advances employer healthcare initiatives at San Diego conference - Traders Union
Why Teladoc Requires Patience at This Time: Buying Is Premature, Selling Is Unwise - Bitget
Teladoc Health, Inc. (TDOC) stock price, news, quote and history - Yahoo Finance UK
North America Telemedicine Robots MarketOutlook 2024-2034 - openPR.com
Why Teladoc Deserves Patience Now: Too Early to Buy, Too Risky to Sell - Yahoo Finance
Value Recap: Does Teladoc Health Inc have a competitive edge2026 Gainers & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Teladoc Health CLO sold $138,583 in TDOC stock - Investing.com
Teladoc (NYSE: TDOC) CAO sells shares to cover RSU tax withholding - Stock Titan
AI in Telehealth & Telemedicine Market Size, Share, Growth 2034 - Fortune Business Insights
Teladoc Health, Inc. (TDOC) Stock Price, News, Quote & History - Yahoo! Finance Canada
Important Notice to Long-Term Shareholders of BellRing - GlobeNewswire
Teladoc Health proposes virtual care model to close gaps in patient engagement - Traders Union
Teladoc (TDOC) Stock Sinks As Market Gains: Here's Why - Yahoo Finance
Teladoc faces pressures following post-pandemic decline - Axios
Teladoc (TDOC) director Susan R. Salka awarded 48,638 restricted stock units - Stock Titan
Teladoc (TDOC) director Susan R. Salka files initial Form 3 ownership - Stock Titan
Teladoc Faces Pressure Over Capital Allocation And Stock Underperformance (UPDATED) - Benzinga
Grabar Law Office Investigates Claims on Behalf of Long-Term Investors of Teladoc Health, Inc. (TDOC) as Class Action Survives Motion to Dismiss - marketscreener.com
Hims & Hers expands personalized digital healthcare platform - MSN
Teladoc Adds Susan Salka to Expanded Board of Directors - The Globe and Mail
Telemedicine Biz Can't Escape Investor Suit Over User Losses - Law360
Pineal Capital Urges Teladoc Health Board Changes - National Today
Activist Pineal Capital pushes Teladoc to consider split, other changes to boost value - MarketScreener
Teladoc (TDOC) Faces Urgent Call for Strategic Changes from Pine - GuruFocus
Teladoc Health Inc (TDOC) Stock Price, Trades & News - GuruFocus
Pinecone Capital Management recently publicly called on the Board of Directors of Teladoc Health Inc. to initiate a comprehensive corporate strategic review and recommended considering the separation of its two core businesses. - Bitget
Teladoc Health stock rises after activist pushes for buyback - Investing.com
Teladoc Health stock rises after activist pushes for buyback By Investing.com - Investing.com India
Pineal Capital Management Issues Open Letter to the Board of Teladoc Health, Inc. - Bluefield Daily Telegraph
Teladoc Health Inc Stock (TDOC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):